Withania somnifera Root Extract Enhances Chemotherapy through ‘Priming’
Fig 2
Oxidative stress alteration following treatment with W. somnifera in cancer and non-cancer cells.
ROS levels were measured using a DCFDA assay following 48 h treatment with 1 μg/mL, 5 μg/mL and 10 μg/mL of W. somnifera root extract in (A) MDA-MB231, (B) HT-29 and (C) MCF10A cells. The bold line in each graph represents control treatment levels for the experiment. Data represent the average of 5 independent experiments ± SEM. *p<0.05 vs non-treatment.